Are ADHD stimulants addictive?

Stimulants are controlled medicines with benefits, unwanted effects and misuse risks that require specialist prescribing and monitoring. Your own risk depends on clinical history and belongs in a prescriber conversation; this page cannot assess it.

Can I get medication without a diagnosis?

No. UK ADHD medication requires a specialist diagnosis and prescription.

What if the first medication does not work?

Tell the prescriber what changed, what did not and what unwanted effects occurred. UK guidance sets out alternatives, but the next option is an individual prescribing decision rather than something a general guide can recommend.

How long does ADHD titration take?

There is no fixed honest estimate. It depends on response, unwanted effects, the treatment being considered and appointment availability. Ask your service how reviews are scheduled, not for a guaranteed completion date.

Can my GP prescribe ADHD medication?

A specialist normally initiates and stabilises ADHD medication. A GP may later prescribe under an agreed shared-care arrangement, with specialist review continuing, but an individual practice can decline the request.

How do ADHD medication, titration and shared care work?

Medication is one evidence-based part of ADHD treatment. Titration is the monitored process of adjusting a prescribed medicine; shared care is an agreement under which a GP may continue prescribing after specialist initiation and stabilisation.

Is medication the only treatment for ADHD?

No. UK guidance describes medication alongside non-medication support and changes to the environment, and reviews of CBT-based approaches for adults report benefits at group level. What suits one person is a clinical conversation.

How are ADHD medication effects monitored?

Prescribing involves monitored adjustment and review, including checking effects and unwanted effects. That is why titration is a process with appointments rather than a single prescription: the dose is adjusted deliberately while someone tracks how you respond. Your job in it is to report changes accurately between appointments.

What if my GP will not take over prescribing?

Shared care is an agreement, not an automatic right, and some practices decline it. The practical route is to ask what would be needed, whether another practice or the specialist service can continue, and to get the answer in writing.

Are ADHD stimulant medicines addictive or dangerous?

Prescribed ADHD medicines are licensed, monitored treatments with known benefits and known unwanted effects, described at population level in comparative reviews. Concerns about misuse are a reason for monitoring, not a reason to avoid the conversation.

What should I do if I cannot get my ADHD medication?

This is a process question, and the process is: speak to the pharmacy about the specific product, then to the prescribing clinician or specialist service, because a change of formulation or brand is a prescribing decision. Do not change how you take a medicine on your own, and do not buy prescription stimulants outside a pharmacy.

Treatment

ADHD medication UK: titration, review and shared care

Reading time: 8 min
Written for: Adults & parents
Sections: 4

The short answer

In the UK, ADHD medication is initiated by an appropriately qualified specialist after diagnosis. The usual process is initiation, monitored titration, ongoing review and — where both specialist and GP agree — shared-care prescribing. If supply is disrupted, contact the pharmacy and prescriber rather than changing dose, switching medicine or sourcing it elsewhere. This page explains the process, not which medicine or dose is right for you.

On this page (4 sections)

01From initiation to titration
02Shared care and your GP
03If your usual medicine cannot be supplied
04Medication is one part of care

From initiation to titration

Titration is the monitored period in which the specialist adjusts treatment while weighing benefit, unwanted effects and physical observations. It happens through review appointments rather than one prescription, and there is no fixed duration that applies to everyone.

Keep a short dated note of what changed, when it changed and how it affected daily function, sleep or appetite, plus any observations your service asks you to record. Report concerning effects promptly and do not alter prescribed treatment without the prescriber.

Shared care and your GP

The specialist remains responsible for initiation and stabilisation. A GP may later agree to prescribe under a shared-care arrangement while specialist reviews continue, but shared care is not automatic and a practice can decline a request.

If it is declined, ask what clinical or local requirement is not met and who will prescribe meanwhile. The specialist service should explain the available route; private patients should establish the ongoing private cost before treatment starts.

If your usual medicine cannot be supplied

Supply changes are time-sensitive but the safe route is stable: ask the dispensing pharmacy what it can fill, then contact the prescriber if the prescription cannot be dispensed. A pharmacist cannot independently rewrite a controlled-drug prescription into a different medicine or dose.

Do not split, ration, substitute, stop or buy prescription medication elsewhere based on internet advice. The prescriber must decide whether a clinically appropriate change is needed; this guide deliberately carries no live stock claims because they date quickly.

Medication is one part of care

UK guidance includes environmental modifications and non-medication support alongside medication where appropriate. CBT-based approaches have a reviewed evidence base for adults; coaching is practical, unregulated support and does not inherit the CBT evidence.

The useful question is not whether medication should replace every other support, but which barriers still need changes at work, school, home or in daily systems after treatment is reviewed.

Questions

Common questions

01
Are ADHD stimulants addictive?: Stimulants are controlled medicines with benefits, unwanted effects and misuse risks that require specialist prescribing and monitoring. Your own risk depends on clinical history and belongs in a prescriber conversation; this page cannot assess it.
02
Can I get medication without a diagnosis?: No. UK ADHD medication requires a specialist diagnosis and prescription.
03
What if the first medication does not work?: Tell the prescriber what changed, what did not and what unwanted effects occurred. UK guidance sets out alternatives, but the next option is an individual prescribing decision rather than something a general guide can recommend.
04
How long does ADHD titration take?: There is no fixed honest estimate. It depends on response, unwanted effects, the treatment being considered and appointment availability. Ask your service how reviews are scheduled, not for a guaranteed completion date.
05
Can my GP prescribe ADHD medication?: A specialist normally initiates and stabilises ADHD medication. A GP may later prescribe under an agreed shared-care arrangement, with specialist review continuing, but an individual practice can decline the request.

Reviewed answers

Reviewed questions on this page

How do ADHD medication, titration and shared care work?: Medication is one evidence-based part of ADHD treatment. Titration is the monitored process of adjusting a prescribed medicine; shared care is an agreement under which a GP may continue prescribing after specialist initiation and stabilisation.Do thisBefore the appointment, write down what you want the medication conversation to cover — how titration is scheduled here, who reviews it, and whether your GP practice takes on shared care afterwards.What this does not settleThis site cannot recommend a medicine, dose, change or stopping plan. Suitability and side effects belong with a qualified prescriber, and a GP may decline shared care.
Why we say this
UK guidance says: NICE sets out medication options, monitoring and the place of non-medication support in ADHD care. National Institute for Health and Care Excellence (Clinical guideline · UK)National Institute for Health and Care Excellence (Guideline evidence review · UK)
Research suggests: Comparative studies describe population-level benefits and harms, not the best medicine for one person. Elliott J and colleagues (Systematic review or meta-analysis · 2020 · International)Ostinelli EG and colleagues (Systematic review or meta-analysis · International)
Is medication the only treatment for ADHD?: No. UK guidance describes medication alongside non-medication support and changes to the environment, and reviews of CBT-based approaches for adults report benefits at group level. What suits one person is a clinical conversation.Do thisAsk at your next appointment what non-medication support is available locally alongside any prescribing decision, and name the two situations where you struggle most so the answer is specific.What this does not settleGroup-level benefit in reviews does not tell you what will help you, and we cannot say whether medication, non-medication support or both belong in your care. That decision is clinical.
Why we say this
UK guidance says: UK guidance sets out medication, non-pharmacological support and environmental modification as part of ADHD care. National Institute for Health and Care Excellence (Clinical guideline · UK)National Institute for Health and Care Excellence (Guideline evidence review · UK)
Research suggests: Reviews of CBT-based support for adults with ADHD report group-level benefits, with variation between studies. Young Z, Moghaddam N, Tickle A (Systematic review or meta-analysis · International)Jensen CM and colleagues (Systematic review or meta-analysis · International)Ren Y and colleagues (Systematic review or meta-analysis · 2025 · International)
How are ADHD medication effects monitored?: Prescribing involves monitored adjustment and review, including checking effects and unwanted effects. That is why titration is a process with appointments rather than a single prescription: the dose is adjusted deliberately while someone tracks how you respond. Your job in it is to report changes accurately between appointments.Do thisKeep a short note between reviews — what changed, when, and how long it lasted — and bring it to the next appointment.What this does not settleHow long titration takes is not fixed: it depends on the medicine, your response and how appointments are scheduled locally, so nobody can honestly give you a timeline in advance. We also cannot tell you whether an effect you are having is a side effect, and we cannot advise on doses. Both belong with your prescriber.
Why we say this
UK guidance says: UK guidance covers medication choice, monitoring and review in ADHD care. National Institute for Health and Care Excellence (Clinical guideline · UK)
Research suggests: Comparative reviews describe population-level benefits and harms of ADHD medicines. Elliott J and colleagues (Systematic review or meta-analysis · 2020 · International)Ostinelli EG and colleagues (Systematic review or meta-analysis · International)
What if my GP will not take over prescribing?: Shared care is an agreement, not an automatic right, and some practices decline it. The practical route is to ask what would be needed, whether another practice or the specialist service can continue, and to get the answer in writing.Do thisAsk the practice, in writing, which part of the shared-care agreement it will not take on, and ask the specialist service what happens to your prescribing while that is unresolved.What this does not settleLocal arrangements differ, and this is not legal advice.
Why we say this
UK practical guidance: ADHD UK’s FAQ and pathway information covers common prescribing and shared-care questions. ADHD UK (Practical guidance · UK)ADHD UK (Practical guidance · UK)
UK guidance says: UK guidance describes specialist involvement in initiating and reviewing ADHD medication. National Institute for Health and Care Excellence (Clinical guideline · UK)
Are ADHD stimulant medicines addictive or dangerous?: Prescribed ADHD medicines are licensed, monitored treatments with known benefits and known unwanted effects, described at population level in comparative reviews. Concerns about misuse are a reason for monitoring, not a reason to avoid the conversation.Do thisWrite your actual worry down in one sentence — misuse, heart health, sleep, appetite, other medicines — and put it to the prescriber directly, because monitoring is designed around exactly that question.What this does not settleWe cannot assess risk for you. Personal history, other conditions and other medicines all matter and belong with a prescriber.
Why we say this
UK guidance says: UK guidance sets out medication options, monitoring and review. National Institute for Health and Care Excellence (Clinical guideline · UK)
Research suggests: Comparative reviews describe population-level benefits and harms rather than individual risk. Elliott J and colleagues (Systematic review or meta-analysis · 2020 · International)Ostinelli EG and colleagues (Systematic review or meta-analysis · International)
What should I do if I cannot get my ADHD medication?: This is a process question, and the process is: speak to the pharmacy about the specific product, then to the prescribing clinician or specialist service, because a change of formulation or brand is a prescribing decision. Do not change how you take a medicine on your own, and do not buy prescription stimulants outside a pharmacy.Do thisContact the prescribing service and the pharmacy the same day, and ask what alternative arrangement they can make.What this does not settleWe deliberately do not publish supply positions, product availability or waiting times: they change, and an out-of-date answer here would be worse than none.
Why we say this
UK guidance says: ADHD medication is initiated and adjusted by specialists with ongoing review; changes are prescribing decisions. National Institute for Health and Care Excellence (Clinical guideline · UK)
UK guidance says: NHS information describes ADHD medicines as prescribed and monitored treatments. NHS (Authoritative health information · UK)

See every reviewed question on this topic

Next step

Understand this betterCoaching, therapy and what each doesWhat the CBT evidence covers, and where coaching differs.

Keep going

Checked against

Attention deficit hyperactivity disorder: diagnosis and management (NG87)
National Institute for Health and Care Excellence · Clinical guideline · UK
The UK clinical guideline for recognising, assessing and managing ADHD, covering diagnosis, impairment, medication, non-medication support and environmental modifications.
Limitations: Describes recognition, assessment and management. It does not establish specific cognitive mechanisms for individual experiences such as task paralysis or overwhelm.
NG87 recommendations
National Institute for Health and Care Excellence · Clinical guideline · UK
The recommendation wording itself — used when we need to be exact about what UK guidance says on adults, medication, non-medication support, environmental modifications and monitoring.
Limitations: Recommendations are for services and clinicians. They are not individual advice and do not explain mechanisms.
NG87 evidence reviews
National Institute for Health and Care Excellence · Guideline evidence review · UK
The evidence reviews sitting beneath the NG87 recommendations, including pharmacological efficacy and safety, non-pharmacological efficacy, combination treatment and information and support.
Limitations: Provenance for guideline decisions rather than a source of standalone claims about everyday experiences.
ADHD in adults
NHS · Authoritative health information · UK
NHS information describing adult ADHD symptoms, onset before age 12, the assessment pathway, GP referral, commonly co-occurring conditions, medication and talking therapies.
Limitations: Describes features and pathways. It does not say why any individual experiences a given difficulty, and it is not a diagnostic tool.
Pharmacologic treatment of ADHD in adults: systematic review and network meta-analysis
Elliott J and colleagues · Systematic review or meta-analysis · 2020 · International
Network meta-analysis comparing benefits, harms and evidence certainty for adult ADHD medication.
Limitations: Comparative research only. It cannot be used for individual prescribing advice.
Comparative efficacy and acceptability of pharmacological, psychological and neurostimulatory interventions for ADHD in adults
Ostinelli EG and colleagues · Systematic review or meta-analysis · International
Component network meta-analysis of contemporary comparative evidence across adult ADHD treatment options.
Limitations: Population-level comparison, not a recommendation for any individual.

Provenance

Last reviewed: September 2026
Reviewed by: the ADHD Resources Hub editorial team. Editorial review, not clinical review — no clinician has signed off this page.

This is health information, not medical advice, and it describes the UK system as generally applied. Local pathways vary. Always check current details with your GP or the provider.